|
|
|
|
|
| Research progress on the application of statins in sepsis associated adult respiratory distress syndrome |
| Qiu Min-shan, Cai Li-hua, Chen Jie, Shao Han-quan, Shen Li-han |
| Intensive Care Unit, Dongguan People's Hospital, Dongguan 523000, China |
|
|
|
|
Abstract Statins are the most commonly used lipid-lowering drugs in the clinic. In recent years, its anti-inflammatory, immunomodulatory, antioxidant and other pleiotropic effects has attracted much attention. At present, there is little progress in the treatment of sepsis associated adult respiratory distress syndrome (ARDS), and become one of the major causes of death in patients with severe infection. The pleiotropic effects of statins and the pathogenesis of sepsis associated ARDS has many correlation, may be an effective drug in the treatment. This paper summarizes research on statins in the treatment of sepsis associated ARDS.
|
|
|
| About author:: Qiu Min-shan, E-mail：missa157@163.com |
|
|
|
| ［1］Li WC, Zou ZJ, Zhou MG, et al. Effects of simvastatin on the expression of inducible NOS in acute lung injury in septic rats［J］. Int J Clin Exp Pathol, 2015, 8(11): 15 106-15 111.
［2］Bernal E, Marín I, Masiá M, et al. Statins in HIV-Infected Patients: Potential Beneficial Effects and Clinical Use［J］. AIDS Rev, 2017, 19(2):59-71.
［3］Oesterle A, Laufs U, Liao JK. Pleiotropic Effects of Statins on the Cardiovascular System［J］. Circ Res, 2017, 120(1):229-243.
［4］Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel［J］. Eur Heart J, 2017, 38(32):2459-2472.
［5］王金波，程国杰，曹树军，等.急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗术前高剂量瑞舒伐他汀对炎性因子和心肌灌注的影响［J］.临床急诊杂志， 2016, 10(2):136.
［6］郑玉强，钱东去. 不同剂量瑞舒伐他汀治疗对ACS急诊PCI术后心脏保护作用的研究［J］.临床急诊杂志， 2016, 10(7):553.
［7］Yusuf S, Bosch J, Dagenais G, et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease［J］. N Engl J Med, 2016, 374(21):2021-2031.
［8］血脂异常老年人使用他汀类药物中国专家共识组. 血脂异常老年人使用他汀类药物中国专家共识［J］. 中华内科杂志, 2015, 54(5):467-477.
［9］Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3)［J］. JAMA, 2016, 315(8): 775-787.
［10］Moussa MD, Santonocito C, Fagnoul D, et al. Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells［J］. Intensive Care Med, 2015, 41(2): 231-238.
［11］Li H, Zhou X, Tan H, et al. Neutrophil extracellular traps contribute to the pathogenesis of acid-aspiration-induced ALI/ARDS［J］. Oncotarget, 2017, 9(2):1772-1784.
［12］Sheu CC, Gong MN, Zhai R, et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS［J］. Chest, 2010, 138(3): 559-567.
［13］Yu Y, Cui Y, Zhao Y, et al. The binding capability of plasma phospholipid transfer protein, but not HDL pool size, is critical to repress LPS induced inflammation［J］. Sci Rep, 2016, 6（9）:20 845.
［14］Palomares O, Akdis M, Martín-Fontecha M, et al. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells［J］. Immunol Rev, 2017, 278(1):219-236.
［15］Tousoulis D, Psarros C, Demosthenous M, et al. Innate and adaptive inflammation as a therapeutic target in vascular disease: the emerging role of statins［J］. J Am Coll Cardiol, 2014, 63(23): 2491-2502.
［16］Psarros C, Economou EK, Koutsilieris M, et al. Statins as pleiotropic modifiers of vascular oxidative stress and inflammation［J］. J Crit Care Med (Targu Mures), 2015, 1(2): 43-54.
［17］Margaritis M, Sanna F, Antoniades C. Statins and oxidative stress in the cardiovascular system［J］. Curr Pharm Des, 2017, 23(9):7040-7047.
［18］Margaritis M, Channon KM, Antoniades C. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering［J］. Antioxid Redox Signal, 2014, 20(8): 1198-1215.
［19］Loughran P A, Lei Z, Xu L, et al. Nitric Oxide in Sepsis and Hemorrhagic Shock: Beneficial or Detrimental［M］. Nitric Oxide, 2017: 289-300.
［20］Xia T, Guan W, Fu J, et al. Tirofiban induces vasorelaxation of the coronary artery via an endothelium-dependent NO-cGMP signaling by activating the PI3K/Akt/eNOS pathway［J］. Biochem Biophys Res Commun, 2016, 474(3): 599-605.
［21］Undas A, Brummel-Ziedins KE, Mann KG. Anticoagulant effects of statins and their clinical implications［J］. Thromb Haemost, 2014, 111(3): 392-400.
［22］Jacobson JR, Barnard JW, Grigoryev DN, et al. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury［J］. Am J Physiol Lung Cell Mol Physiol, 2005, 288(6): L1026-L1032.
［23］Takano K, Yamamoto S, Tomita K, et al. Successful treatment of acute lung injury with pitavastatin in septic mice: potential role of glucocorticoid receptor expression in alveolar macrophages［J］. J Pharmacol Exp Ther, 2011, 336(2): 381-390.
［24］Shyamsundar M, McKeown STW, O′Kane CM, et al. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers［J］. Am J Respir Crit Care Med, 2009, 179(12): 1107-1114.
［25］Mansur A, Steinau M, Popov AF, et al. Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome(ARDS) depends on ARDS severity: a prospective observational cohort study［J］. BMC Med, 2015, 13(1):128.
［26］Dinglas VD, Hopkins RO, Wozniak AW, et al. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial［J］. Thorax, 2016, 71(5):401-410.
［27］Truwit JD, Bernard GR, Steingrub J, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome［J］. N Engl J Med, 2014, 370(23): 2191-2200.
［28］Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016［J］. Crit Care Med, 2017, 45(3):486-552. |
|
|
|
Address: 1 North 2nd Street,
Zhongguancun, 
